Dive Deeper

Below is a list of topic-based articles on mental health or substance use that dive deeper into topics discussed in the web library. Articles are updated monthly and are sorted by publication date, with the newest articles at the top.

Substance Use

News Articles

• Legislature forms committee to address Oregon’s addiction epidemic
• Brandon Act requires commanders to connect troops to mental health help
• California lawmakers consider plan to cap Naloxone cost at $10
• A prison pipeline that could help meet Oregon’s behavioral health workforce needs
• First Measure 110-funded detox opens, will focus on fentanyl and alcohol
• Serve a drink, then save a life: This is restaurant work during the opioid epidemic
• FDA approves first opioid reversal drug from a nonprofit company
• A new bipartisan bill aims to increase access to fentanyl test strips amid overdose deaths
• States stiffen penalties for fentanyl, despite public health concerns
• Once-resistant rural courts begin to embrace medications to treat addiction
• More people accessing help under Measure 110 but gaps in services, data remain
• The DEA relaxed online prescribing rules during Covid. Now it wants to rein them in.
• FDA creates path for psychedelic drug trials
• Find out how much opioid settlement cash your locality received
• Teens seeking addiction care unlikely to be offered standard medication
• Meth, fentanyl pose new problems for overwhelmed detox providers
• How state laws flag pregnant patients with opioid use disorder to protective services
• A new nasal spray to reverse fentanyl and other opioid overdoses gets FDA approval
• ‘No child should be dying’: Fentanyl-related deaths among kids rising, Yale study says
• Addiction treatment medicine is vastly underprescribed, especially by race, study finds
• Most Oregon prisoners can’t get addiction treatment; there’s a bill to change that
• New DEA requirements may limit access to buprenorphine, a popular drug for opioid recovery
• Over-the-counter Narcan to cost less than $50 for a two-pack, company says
• Ageism, stigma hinders response to senior alcohol use disorder
• First state-regulated overdose prevention center in US slated to open in Rhode Island in early 2024
• Oregon Senate passes legislation to fight opioid overdoses
• Oregon bill to teach students about opioid dangers passes the Senate
• Oregon lawmakers struggle to improve drug monitoring tool
• $50 billion in opioid settlement cash is on the way. We’re tracking how it’s spent.
• Congress moves to make xylazine a controlled substance
• FDA approves first over-the-counter version of opioid overdose antidote Narcan
• Idaho lawmakers vote to limit who can access fentanyl overdose treatment through grant
• Some roadblocks to lifesaving addiction treatment are gone. Now what?
• With overdoses up, states look at harsher fentanyl penalties
• Study: Disabled people less likely to be prescribed medication for opioid disorder
• State inaction left Oregon teens vulnerable to fentanyl’s fatal spread
• As opioid crisis reaches new peaks, future of overdose prevention sites in Colorado remains unclear
• Opioid overdose risk 10 times greater for those recently released from prison, research shows
• Advocates, lawmakers warn that Biden telehealth rule will worsen opioid crisis
• Bill seeks personal data collection on people who use legal psilocybin in Oregon
• Addiction treatment may be coming to a pharmacy near you
• Addiction drug prices vary widely
• Native Americans left out of 'deaths of despair' research
• Legislation to slow opioid overdoses draws broad support
• Vending machines with lifesaving drug grow as opioid crisis rages in US
• Hospitals look to storytelling to reduce stigma toward people with addiction
• Buprenorphine deaths did not increase despite wider access during pandemic, study shows
• Changes to Measure 110 likely this legislative session
• Insufficient data and reporting pose greatest risk to Measure 110, audit finds
• Flavored cannabis marketing is criticized for targeting kids
• ‘Microdosing’ allowed under Oregon’s new psilocybin program
• Bills to make naloxone more accessible seek to slow opioid fatalities in Oregon
• Legal use of hallucinogenic mushrooms begins in Oregon
• OHSU to test if rewarding safer drug use reduces fatal overdoses in Oregon
• Have a safe trip: Oregon trains magic mushroom facilitators
• Final tally: Nearly 107,000 US overdose deaths last year
• Fentanyl awareness campaign urges parents to ‘Drop the F-Bomb’ with their kids
• Addiction treatment got easier during Covid. A new proposal would keep it that way
• Oregon’s addiction care rollout puts peers in a precarious position
• People with disabilities who misuse opioid drugs 73% more likely to attempt suicide, national study finds
• More than 180,000 people overdosed on opioids and survived in the past year, new White House dashboard shows
• This breakthrough fentanyl vaccine could help curb the opioid crisis
• Addiction treatment proponents urge rural clinicians to pitch in by prescribing medication
• Older adults face Medicare hurdles for substance use treatment
• HHS moves to overhaul privacy rules for substance abuse patients
• Schools, sheriffs, and syringes: State plans vary for spending $26B in opioid settlement funds
• FDA opens door to make opioid overdose antidote available over the counter
• The player-coaches of addiction recovery work without boundaries
• Oregon counties largely vote against psilocybin use
• Medication treatment for addiction is shorter for Black and Hispanic patients, study finds
• FDA alerts health care professionals of risks to patients exposed to xylazine in illicit drugs
• CDC issues new opioid prescribing guidance, giving doctors more leeway to treat pain
• A new paramedic policy may guide overdose patients into treatment
• Hospitals have been slow to bring on addiction specialists
• New survey suggests little progress against U.S. teen vaping
• Rise in deaths spurs effort to raise alcohol taxes
• Candy, cash, gifts: How rewards help recovery from addiction
• Three Portland-area counties will distribute 20,000 doses of naloxone to stem opioid deaths
• Federal law enforcement officials warn of "rainbow fentanyl" appearing in Oregon
• Using both meth and opioids drives overdoses in rural Oregon, study finds
• They call it ‘tranq’ — And it’s making street drugs even more dangerous
• Oregon’s meth problem: More money than leadership
• Meth has changed, and it’s sabotaging Oregon’s mental health system
• As overdose deaths exploded during the pandemic, racial disparities widened, CDC report shows
• Relaxed methadone rules appear safe, researchers find
• U.S. drug overdose deaths surpass 107,000 last year, another record
• Teen overdose rates doubled in two years due to fentanyl
• With overdoses at record highs, a veterinary tranquilizer spreading through the U.S. drug supply poses new threats
• Xylazine, a dangerous animal sedative, is contaminating Philly’s drug supply
• Parents warn of fentanyl danger after two Portland students die from accidental overdoses
• The loophole that’s fueling a return to teenage vaping
• Black Americans are now dying from drug overdoses at a higher rate than whites
• Q&A: Surgeon General on omicron, masks and mental health
• Opioid fight needs new strategy, Cabinet leadership: Report
• Overdose deaths cost US $1 trillion annually, bipartisan report finds
• Over 1 million years of life lost to drug overdoses
• Top 10 relapse prevention skills

Scholarly Articles

• Treatments used among adolescent residential addiction treatment facilities in the US, 2022
• Racial inequality in receipt of medications for opioid use disorder
• National trends in pediatric deaths from fentanyl, 1999-2021
• Fatal and nonfatal opioid overdose risk following release from prison: A retrospective cohort study using linked administrative data
• Quality of opioid use disorder treatment for persons with and without disabling conditions
• Characteristics of fatal poisonings among infants and young children in the United States
• Trends in out-of-pocket costs for and characteristics of pharmacy-dispensed buprenorphine medications for opioid use disorder treatment by type of payer, 2015 to 2020
• Trends and characteristics of buprenorphine-involved overdose deaths prior to and during the COVID-19 pandemic
• An immunconjugate vaccine alters distribution and reduces the antinociceptive, behavioral and physiological effects of fentanyl in male and female rats
• Racial and ethnic disparities in buprenorphine treatment duration in the US
• Percentage of heavy drinking days following psilocybin-assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder: A randomized clinical trial
• Adolescent and adult time trends in US hallucinogen use, 2002–19: any use, and use of ecstasy, LSD and PCP
• Association of methamphetamine and opioid use with nonfatal overdose in rural communities
• Aided recall of The Real Cost e-cigarette prevention advertisements among a nationally representative sample of adolescents
• Vital signs: Drug overdose deaths, by selected sociodemographic and social determinants of health characteristics — 25 states and the District of Columbia, 2019–2020
• Methadone-involved overdose deaths in the US before and after federal policy changes expanding take-home methadone doses from opioid treatment programs
• Epidemiological trends in opioid-only and opioid/polysubstance-related death rates among American Indian/Alaska Native populations from 1999 to 2019: a retrospective longitudinal ecological study
• Xylazine spreads across the US: A growing component of the increasingly synthetic and polysubstance overdose crisis
• Why Deaths of Despair are increasing in the US and not other industrial nations—Insights from neuroscience and anthropology
• Evaluating adolescent substance use and suicide in the pediatric emergency department
• The fourth wave of the US opioid epidemic and its implications for the rural US: A federal perspective
• Methamphetamine use, methamphetamine use disorder, and associated overdose Deaths among US adults
• The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis
• Drugs, brains, and behavior: The science of addiction
• Co-use of methamphetamine and opioids among people in treatment in Oregon: A qualitative examination of interrelated structural, community, and individual-level factors
• A clash of epidemics: Impact of the COVID-19 pandemic response on opioid overdose